Reporting violations "Whistleblowing"

“Whistleblowing” report for Savio Group Companies (Farmaci & Salute Holding S.r.l. – I.B.N. Savio S.r.l. – Savio Industrial S.r.l. – Farmaceutici Caber S.r.l. – Savio Pharma Italia S.r.l.)

The Savio Group, in compliance and in pursuant to the provisions referred to in Legislative Decree no. 24 of March 10, 2023, implementing Directive (EU) 2019/1937 of the European Parliament and of the Council of October 23, 2019, on the protection of persons reporting breaches of Union law and national legislation, has implemented a “Whistleblowing” Reporting System containing detailed indications of the subject matter of the reports, as well as the related channels and operational methods for making reports concerning violations of national legislation and EU legislation that harm the public interest or the integrity of the Savio Group.

The key points are outlined in the “Information and operational guidelines on whistleblowing” prepared by the Savio Group.

The processing of the reporter’s data is specified in the “Privacy Policy” with the corresponding “Consent for processing personal data” of the reporter to be sent completed to the Reporting Officer “Whistleblowing”.

The “Whistleblowing” reporting management system involves the use of an IT platform managed with full respect for the protection of the reporter’s identity.

The platform allows for reporting, even anonymously, violations, alleged or known, of rules, laws, procedures, company policies, as well as unlawful behaviors, ensuring the maximum confidentiality of the reporter.

To make a report through the online platform “EQS Integrity Line Professional”, the link to be used is https://wbgrupposavio.integrityline.com/